These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 28643018)

  • 1. Heterogeneity of GATA2-related myeloid neoplasms.
    Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
    Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
    Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
    Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA2 deficiency and related myeloid neoplasms.
    Wlodarski MW; Collin M; Horwitz MS
    Semin Hematol; 2017 Apr; 54(2):81-86. PubMed ID: 28637621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and molecular characteristics of GATA2 related pediatric primary myelodysplastic syndrome].
    An WB; Liu C; Wan Y; Chen XY; Guo Y; Chen XJ; Yang WY; Chen YM; Zhang YC; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):477-483. PubMed ID: 31340620
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.
    Sakata N; Okano M; Masako R; Tanaka A; Yamashita Y; Karasuno T; Imadome KI; Okada M; Sugimoto K
    Int J Hematol; 2021 Feb; 113(2):290-296. PubMed ID: 32865708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
    Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
    Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
    Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
    Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
    Sahoo SS; Kozyra EJ; Wlodarski MW
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
    Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
    Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.
    Bortnick R; Wlodarski M; de Haas V; De Moerloose B; Dworzak M; Hasle H; Masetti R; Starý J; Turkiewicz D; Ussowicz M; Kozyra E; Albert M; Bader P; Bordon V; Cario G; Beier R; Schulte J; Bresters D; Müller I; Pichler H; Sedlacek P; Sauer MG; Zecca M; Göhring G; Yoshimi A; Noellke P; Erlacher M; Locatelli F; Niemeyer CM; Strahm B;
    Bone Marrow Transplant; 2021 Nov; 56(11):2732-2741. PubMed ID: 34244664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of germline GATA2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7.
    Yoshida M; Tanase-Nakao K; Shima H; Shirai R; Yoshida K; Osumi T; Deguchi T; Mori M; Arakawa Y; Takagi M; Miyamura T; Sakaguchi K; Toyoda H; Ishida H; Sakata N; Imamura T; Kawahara Y; Morimoto A; Koike T; Yagasaki H; Ito S; Tomizawa D; Kiyokawa N; Narumi S; Kato M
    Br J Haematol; 2020 Dec; 191(5):835-843. PubMed ID: 32770553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
    Rajput RV; Arnold DE
    Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
    Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
    Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity.
    Johnson KD; Hsu AP; Ryu MJ; Wang J; Gao X; Boyer ME; Liu Y; Lee Y; Calvo KR; Keles S; Zhang J; Holland SM; Bresnick EH
    J Clin Invest; 2012 Oct; 122(10):3692-704. PubMed ID: 22996659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
    Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
    Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
    Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
    Shimizu R; Yamamoto M
    IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency.
    Kozyra EJ; Pastor VB; Lefkopoulos S; Sahoo SS; Busch H; Voss RK; Erlacher M; Lebrecht D; Szvetnik EA; Hirabayashi S; Pasaulienė R; Pedace L; Tartaglia M; Klemann C; Metzger P; Boerries M; Catala A; Hasle H; de Haas V; Kállay K; Masetti R; De Moerloose B; Dworzak M; Schmugge M; Smith O; Starý J; Mejstrikova E; Ussowicz M; Morris E; Singh P; Collin M; Derecka M; Göhring G; Flotho C; Strahm B; Locatelli F; Niemeyer CM; Trompouki E; Wlodarski MW;
    Leukemia; 2020 Oct; 34(10):2673-2687. PubMed ID: 32555368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation.
    Sato Y; Fukatsu M; Suzuki T; Sasajima T; Gunji N; Yoshida S; Asano N; Fukuchi K; Mori H; Takano M; Hayashi K; Takahashi H; Shirado-Harada K; Kimura S; Koyama D; Migita K; Ikezoe T
    Int J Hematol; 2023 Nov; 118(5):642-646. PubMed ID: 37084069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.